Global Pharmaceutical Intermediates Sales Market Report 2021

Publisher Name :
Date: 08-Apr-2021
No. of pages: 147
Inquire Before Buying

The global Pharmaceutical Intermediates market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pharmaceutical Intermediates market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type

- GMP

- Non-GMP

Segment by Application

- Antibiotics

- Antipyretic Analgesics

- Vitamins

- Others

The Pharmaceutical Intermediates market is analysed and market size information is provided by regions (countries). Segment by Application, the Pharmaceutical Intermediates market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company

- Lonza

- Catalent

- Patheon

- Jubilant

- Granules

- Ganesh

- Chemcon

- BASF

- Porton

- Lianhetech

- ABA Chem

- Tianma

- Jiujiujiu

- Alpha

- Jiuzhou

- Yongtai

Global Pharmaceutical Intermediates Sales Market Report 2021

Table of Contents
1 Pharmaceutical Intermediates Market Overview
1.1 Pharmaceutical Intermediates Product Scope
1.2 Pharmaceutical Intermediates Segment by Type
1.2.1 Global Pharmaceutical Intermediates Sales by Type (2016 & 2021 & 2027)
1.2.2 GMP
1.2.3 Non-GMP
1.3 Pharmaceutical Intermediates Segment by Application
1.3.1 Global Pharmaceutical Intermediates Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Antibiotics
1.3.3 Antipyretic Analgesics
1.3.4 Vitamins
1.3.5 Others
1.4 Pharmaceutical Intermediates Market Estimates and Forecasts (2016-2027)
1.4.1 Global Pharmaceutical Intermediates Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Pharmaceutical Intermediates Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Pharmaceutical Intermediates Price Trends (2016-2027)
2 Pharmaceutical Intermediates Estimates and Forecasts by Region
2.1 Global Pharmaceutical Intermediates Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Pharmaceutical Intermediates Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Pharmaceutical Intermediates Sales Market Share by Region (2016-2021)
2.2.2 Global Pharmaceutical Intermediates Revenue Market Share by Region (2016-2021)
2.3 Global Pharmaceutical Intermediates Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Pharmaceutical Intermediates Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Pharmaceutical Intermediates Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Pharmaceutical Intermediates Estimates and Projections (2016-2027)
2.4.2 Europe Pharmaceutical Intermediates Estimates and Projections (2016-2027)
2.4.3 China Pharmaceutical Intermediates Estimates and Projections (2016-2027)
2.4.4 Japan Pharmaceutical Intermediates Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Pharmaceutical Intermediates Estimates and Projections (2016-2027)
2.4.6 India Pharmaceutical Intermediates Estimates and Projections (2016-2027)
3 Global Pharmaceutical Intermediates Competition Landscape by Players
3.1 Global Top Pharmaceutical Intermediates Players by Sales (2016-2021)
3.2 Global Top Pharmaceutical Intermediates Players by Revenue (2016-2021)
3.3 Global Pharmaceutical Intermediates Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pharmaceutical Intermediates as of 2020)
3.4 Global Pharmaceutical Intermediates Average Price by Company (2016-2021)
3.5 Manufacturers Pharmaceutical Intermediates Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Pharmaceutical Intermediates Market Size by Type
4.1 Global Pharmaceutical Intermediates Historic Market Review by Type (2016-2021)
4.1.1 Global Pharmaceutical Intermediates Sales Market Share by Type (2016-2021)
4.1.2 Global Pharmaceutical Intermediates Revenue Market Share by Type (2016-2021)
4.1.3 Global Pharmaceutical Intermediates Price by Type (2016-2021)
4.2 Global Pharmaceutical Intermediates Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Pharmaceutical Intermediates Sales Forecast by Type (2022-2027)
4.2.2 Global Pharmaceutical Intermediates Revenue Forecast by Type (2022-2027)
4.2.3 Global Pharmaceutical Intermediates Price Forecast by Type (2022-2027)
5 Global Pharmaceutical Intermediates Market Size by Application
5.1 Global Pharmaceutical Intermediates Historic Market Review by Application (2016-2021)
5.1.1 Global Pharmaceutical Intermediates Sales Market Share by Application (2016-2021)
5.1.2 Global Pharmaceutical Intermediates Revenue Market Share by Application (2016-2021)
5.1.3 Global Pharmaceutical Intermediates Price by Application (2016-2021)
5.2 Global Pharmaceutical Intermediates Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Pharmaceutical Intermediates Sales Forecast by Application (2022-2027)
5.2.2 Global Pharmaceutical Intermediates Revenue Forecast by Application (2022-2027)
5.2.3 Global Pharmaceutical Intermediates Price Forecast by Application (2022-2027)
6 North America Pharmaceutical Intermediates Market Facts & Figures
6.1 North America Pharmaceutical Intermediates Sales by Company
6.1.1 North America Pharmaceutical Intermediates Sales by Company (2016-2021)
6.1.2 North America Pharmaceutical Intermediates Revenue by Company (2016-2021)
6.2 North America Pharmaceutical Intermediates Sales Breakdown by Type
6.2.1 North America Pharmaceutical Intermediates Sales Breakdown by Type (2016-2021)
6.2.2 North America Pharmaceutical Intermediates Sales Breakdown by Type (2022-2027)
6.3 North America Pharmaceutical Intermediates Sales Breakdown by Application
6.3.1 North America Pharmaceutical Intermediates Sales Breakdown by Application (2016-2021)
6.3.2 North America Pharmaceutical Intermediates Sales Breakdown by Application (2022-2027)
7 Europe Pharmaceutical Intermediates Market Facts & Figures
7.1 Europe Pharmaceutical Intermediates Sales by Company
7.1.1 Europe Pharmaceutical Intermediates Sales by Company (2016-2021)
7.1.2 Europe Pharmaceutical Intermediates Revenue by Company (2016-2021)
7.2 Europe Pharmaceutical Intermediates Sales Breakdown by Type
7.2.1 Europe Pharmaceutical Intermediates Sales Breakdown by Type (2016-2021)
7.2.2 Europe Pharmaceutical Intermediates Sales Breakdown by Type (2022-2027)
7.3 Europe Pharmaceutical Intermediates Sales Breakdown by Application
7.3.1 Europe 147 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 147 Sales Breakdown by Application (2022-2027)
8 China Pharmaceutical Intermediates Market Facts & Figures
8.1 China Pharmaceutical Intermediates Sales by Company
8.1.1 China Pharmaceutical Intermediates Sales by Company (2016-2021)
8.1.2 China Pharmaceutical Intermediates Revenue by Company (2016-2021)
8.2 China Pharmaceutical Intermediates Sales Breakdown by Type
8.2.1 China Pharmaceutical Intermediates Sales Breakdown by Type (2016-2021)
8.2.2 China Pharmaceutical Intermediates Sales Breakdown by Type (2022-2027)
8.3 China Pharmaceutical Intermediates Sales Breakdown by Application
8.3.1 China 315 Sales Breakdown by Application (2016-2021)
8.3.2 China 315 Sales Breakdown by Application (2022-2027)
9 Japan Pharmaceutical Intermediates Market Facts & Figures
9.1 Japan Pharmaceutical Intermediates Sales by Company
9.1.1 Japan Pharmaceutical Intermediates Sales by Company (2016-2021)
9.1.2 Japan Pharmaceutical Intermediates Revenue by Company (2016-2021)
9.2 Japan Pharmaceutical Intermediates Sales Breakdown by Type
9.2.1 Japan Pharmaceutical Intermediates Sales Breakdown by Type (2016-2021)
9.2.2 Japan Pharmaceutical Intermediates Sales Breakdown by Type (2022-2027)
9.3 Japan Pharmaceutical Intermediates Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Pharmaceutical Intermediates Market Facts & Figures
10.1 Southeast Asia Pharmaceutical Intermediates Sales by Company
10.1.1 Southeast Asia Pharmaceutical Intermediates Sales by Company (2016-2021)
10.1.2 Southeast Asia Pharmaceutical Intermediates Revenue by Company (2016-2021)
10.2 Southeast Asia Pharmaceutical Intermediates Sales Breakdown by Type
10.2.1 Southeast Asia Pharmaceutical Intermediates Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Pharmaceutical Intermediates Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Pharmaceutical Intermediates Sales Breakdown by Application
10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)
11 India Pharmaceutical Intermediates Market Facts & Figures
11.1 India Pharmaceutical Intermediates Sales by Company
11.1.1 India Pharmaceutical Intermediates Sales by Company (2016-2021)
11.1.2 India Pharmaceutical Intermediates Revenue by Company (2016-2021)
11.2 India Pharmaceutical Intermediates Sales Breakdown by Type
11.2.1 India Pharmaceutical Intermediates Sales Breakdown by Type (2016-2021)
11.2.2 India Pharmaceutical Intermediates Sales Breakdown by Type (2022-2027)
11.3 India Pharmaceutical Intermediates Sales Breakdown by Application
11.3.1 India Pharmaceutical Intermediates Sales Breakdown by Application (2016-2021)
11.3.2 India Pharmaceutical Intermediates Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Pharmaceutical Intermediates Business
12.1 Lonza
12.1.1 Lonza Corporation Information
12.1.2 Lonza Business Overview
12.1.3 Lonza Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Lonza Pharmaceutical Intermediates Products Offered
12.1.5 Lonza Recent Development
12.2 Catalent
12.2.1 Catalent Corporation Information
12.2.2 Catalent Business Overview
12.2.3 Catalent Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Catalent Pharmaceutical Intermediates Products Offered
12.2.5 Catalent Recent Development
12.3 Patheon
12.3.1 Patheon Corporation Information
12.3.2 Patheon Business Overview
12.3.3 Patheon Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Patheon Pharmaceutical Intermediates Products Offered
12.3.5 Patheon Recent Development
12.4 Jubilant
12.4.1 Jubilant Corporation Information
12.4.2 Jubilant Business Overview
12.4.3 Jubilant Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Jubilant Pharmaceutical Intermediates Products Offered
12.4.5 Jubilant Recent Development
12.5 Granules
12.5.1 Granules Corporation Information
12.5.2 Granules Business Overview
12.5.3 Granules Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Granules Pharmaceutical Intermediates Products Offered
12.5.5 Granules Recent Development
12.6 Ganesh
12.6.1 Ganesh Corporation Information
12.6.2 Ganesh Business Overview
12.6.3 Ganesh Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Ganesh Pharmaceutical Intermediates Products Offered
12.6.5 Ganesh Recent Development
12.7 Chemcon
12.7.1 Chemcon Corporation Information
12.7.2 Chemcon Business Overview
12.7.3 Chemcon Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Chemcon Pharmaceutical Intermediates Products Offered
12.7.5 Chemcon Recent Development
12.8 BASF
12.8.1 BASF Corporation Information
12.8.2 BASF Business Overview
12.8.3 BASF Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
12.8.4 BASF Pharmaceutical Intermediates Products Offered
12.8.5 BASF Recent Development
12.9 Porton
12.9.1 Porton Corporation Information
12.9.2 Porton Business Overview
12.9.3 Porton Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Porton Pharmaceutical Intermediates Products Offered
12.9.5 Porton Recent Development
12.10 Lianhetech
12.10.1 Lianhetech Corporation Information
12.10.2 Lianhetech Business Overview
12.10.3 Lianhetech Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Lianhetech Pharmaceutical Intermediates Products Offered
12.10.5 Lianhetech Recent Development
12.11 ABA Chem
12.11.1 ABA Chem Corporation Information
12.11.2 ABA Chem Business Overview
12.11.3 ABA Chem Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
12.11.4 ABA Chem Pharmaceutical Intermediates Products Offered
12.11.5 ABA Chem Recent Development
12.12 Tianma
12.12.1 Tianma Corporation Information
12.12.2 Tianma Business Overview
12.12.3 Tianma Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Tianma Pharmaceutical Intermediates Products Offered
12.12.5 Tianma Recent Development
12.13 Jiujiujiu
12.13.1 Jiujiujiu Corporation Information
12.13.2 Jiujiujiu Business Overview
12.13.3 Jiujiujiu Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Jiujiujiu Pharmaceutical Intermediates Products Offered
12.13.5 Jiujiujiu Recent Development
12.14 Alpha
12.14.1 Alpha Corporation Information
12.14.2 Alpha Business Overview
12.14.3 Alpha Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Alpha Pharmaceutical Intermediates Products Offered
12.14.5 Alpha Recent Development
12.15 Jiuzhou
12.15.1 Jiuzhou Corporation Information
12.15.2 Jiuzhou Business Overview
12.15.3 Jiuzhou Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Jiuzhou Pharmaceutical Intermediates Products Offered
12.15.5 Jiuzhou Recent Development
12.16 Yongtai
12.16.1 Yongtai Corporation Information
12.16.2 Yongtai Business Overview
12.16.3 Yongtai Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Yongtai Pharmaceutical Intermediates Products Offered
12.16.5 Yongtai Recent Development
13 Pharmaceutical Intermediates Manufacturing Cost Analysis
13.1 Pharmaceutical Intermediates Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Pharmaceutical Intermediates
13.4 Pharmaceutical Intermediates Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Pharmaceutical Intermediates Distributors List
14.3 Pharmaceutical Intermediates Customers
15 Market Dynamics
15.1 Pharmaceutical Intermediates Market Trends
15.2 Pharmaceutical Intermediates Drivers
15.3 Pharmaceutical Intermediates Market Challenges
15.4 Pharmaceutical Intermediates Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Pharmaceutical Intermediates Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Pharmaceutical Intermediates Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Pharmaceutical Intermediates Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Pharmaceutical Intermediates Sales (K MT) by Region (2016-2021)
Table 5. Global Pharmaceutical Intermediates Sales Market Share by Region (2016-2021)
Table 6. Global Pharmaceutical Intermediates Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Pharmaceutical Intermediates Revenue Share by Region (2016-2021)
Table 8. Global Pharmaceutical Intermediates Sales (K MT) Forecast by Region (2022-2027)
Table 9. Global Pharmaceutical Intermediates Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Pharmaceutical Intermediates Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Pharmaceutical Intermediates Revenue Share Forecast by Region (2022-2027)
Table 12. Global Pharmaceutical Intermediates Sales (K MT) of Key Companies (2016-2021)
Table 13. Global Pharmaceutical Intermediates Sales Share by Company (2016-2021)
Table 14. Global Pharmaceutical Intermediates Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Pharmaceutical Intermediates Revenue Share by Company (2016-2021)
Table 16. Global Pharmaceutical Intermediates by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutical Intermediates as of 2020)
Table 17. Global Pharmaceutical Intermediates Average Price (USD/MT) of Key Company (2016-2021)
Table 18. Manufacturers Pharmaceutical Intermediates Manufacturing Sites and Area Served
Table 19. Manufacturers Pharmaceutical Intermediates Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Pharmaceutical Intermediates Sales (K MT) by Type (2016-2021)
Table 22. Global Pharmaceutical Intermediates Sales Share by Type (2016-2021)
Table 23. Global Pharmaceutical Intermediates Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Pharmaceutical Intermediates Price (USD/MT) by Type (2016-2021)
Table 25. Global Pharmaceutical Intermediates Sales Share by Type (2022-2027)
Table 26. Global Pharmaceutical Intermediates Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Pharmaceutical Intermediates Revenue Share by Type (2022-2027)
Table 28. Global Pharmaceutical Intermediates Price (USD/MT) by Type (2022-2027)
Table 29. Global Pharmaceutical Intermediates Sales (K MT) by Application (2016-2021)
Table 30. Global Pharmaceutical Intermediates Sales Share by Application (2016-2021)
Table 31. Global Pharmaceutical Intermediates Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Pharmaceutical Intermediates Price (USD/MT) by Application (2016-2021)
Table 33. Global Pharmaceutical Intermediates Sales (K MT) by Application (2022-2027)
Table 34. Global Pharmaceutical Intermediates Sales Share by Application (2022-2027)
Table 35. Global Pharmaceutical Intermediates Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Pharmaceutical Intermediates Revenue Share by Application (2022-2027)
Table 37. Global Pharmaceutical Intermediates Price (USD/MT) by Application (2022-2027)
Table 38. North America Pharmaceutical Intermediates Sales (K MT) by Company (2016-2021)
Table 39. North America Pharmaceutical Intermediates Sales Market Share by Company (2016-2021)
Table 40. North America Pharmaceutical Intermediates Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Pharmaceutical Intermediates Revenue Market Share by Company (2016-2021)
Table 42. North America Pharmaceutical Intermediates Sales by Type (2016-2021) & (K MT)
Table 43. North America Pharmaceutical Intermediates Sales Market Share by Type (2016-2021)
Table 44. North America Pharmaceutical Intermediates Sales by Type (2022-2027) & (K MT)
Table 45. North America Pharmaceutical Intermediates Sales Market Share by Type (2022-2027)
Table 46. North America Pharmaceutical Intermediates Sales by Application (2016-2021) & (K MT)
Table 47. North America Pharmaceutical Intermediates Sales Market Share by Application (2016-2021)
Table 48. North America Pharmaceutical Intermediates Sales by Application (2022-2027) & (K MT)
Table 49. North America Pharmaceutical Intermediates Sales Market Share by Application (2022-2027)
Table 50. Europe Pharmaceutical Intermediates Sales (K MT) by Company (2016-2021)
Table 51. Europe Pharmaceutical Intermediates Sales Market Share by Company (2016-2021)
Table 52. Europe Pharmaceutical Intermediates Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Pharmaceutical Intermediates Revenue Market Share by Company (2016-2021)
Table 54. Europe Pharmaceutical Intermediates Sales by Type (2016-2021) & (K MT)
Table 55. Europe Pharmaceutical Intermediates Sales Market Share by Type (2016-2021)
Table 56. Europe Pharmaceutical Intermediates Sales by Type (2022-2027) & (K MT)
Table 57. Europe Pharmaceutical Intermediates Sales Market Share by Type (2022-2027)
Table 58. Europe Pharmaceutical Intermediates Sales by Application (2016-2021) & (K MT)
Table 59. Europe Pharmaceutical Intermediates Sales Market Share by Application (2016-2021)
Table 60. Europe Pharmaceutical Intermediates Sales by Application (2022-2027) & (K MT)
Table 61. Europe Pharmaceutical Intermediates Sales Market Share by Application (2022-2027)
Table 62. China Pharmaceutical Intermediates Sales (K MT) by Company (2016-2021)
Table 63. China Pharmaceutical Intermediates Sales Market Share by Company (2016-2021)
Table 64. China Pharmaceutical Intermediates Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Pharmaceutical Intermediates Revenue Market Share by Company (2016-2021)
Table 66. China Pharmaceutical Intermediates Sales by Type (2016-2021) & (K MT)
Table 67. China Pharmaceutical Intermediates Sales Market Share by Type (2016-2021)
Table 68. China Pharmaceutical Intermediates Sales by Type (2022-2027) & (K MT)
Table 69. China Pharmaceutical Intermediates Sales Market Share by Type (2022-2027)
Table 70. China Pharmaceutical Intermediates Sales by Application (2016-2021) & (K MT)
Table 71. China Pharmaceutical Intermediates Sales Market Share by Application (2016-2021)
Table 72. China Pharmaceutical Intermediates Sales by Application (2022-2027) & (K MT)
Table 73. China Pharmaceutical Intermediates Sales Market Share by Application (2022-2027)
Table 74. Japan Pharmaceutical Intermediates Sales (K MT) by Company (2016-2021)
Table 75. Japan Pharmaceutical Intermediates Sales Market Share by Company (2016-2021)
Table 76. Japan Pharmaceutical Intermediates Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Pharmaceutical Intermediates Revenue Market Share by Company (2016-2021)
Table 78. Japan Pharmaceutical Intermediates Sales by Type (2016-2021) & (K MT)
Table 79. Japan Pharmaceutical Intermediates Sales Market Share by Type (2016-2021)
Table 80. Japan Pharmaceutical Intermediates Sales by Type (2022-2027) & (K MT)
Table 81. Japan Pharmaceutical Intermediates Sales Market Share by Type (2022-2027)
Table 82. Japan Pharmaceutical Intermediates Sales by Application (2016-2021) & (K MT)
Table 83. Japan Pharmaceutical Intermediates Sales Market Share by Application (2016-2021)
Table 84. Japan Pharmaceutical Intermediates Sales by Application (2022-2027) & (K MT)
Table 85. Japan Pharmaceutical Intermediates Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Pharmaceutical Intermediates Sales (K MT) by Company (2016-2021)
Table 87. Southeast Asia Pharmaceutical Intermediates Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Pharmaceutical Intermediates Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Pharmaceutical Intermediates Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Pharmaceutical Intermediates Sales by Type (2016-2021) & (K MT)
Table 91. Southeast Asia Pharmaceutical Intermediates Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Pharmaceutical Intermediates Sales by Type (2022-2027) & (K MT)
Table 93. Southeast Asia Pharmaceutical Intermediates Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Pharmaceutical Intermediates Sales by Application (2016-2021) & (K MT)
Table 95. Southeast Asia Pharmaceutical Intermediates Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Pharmaceutical Intermediates Sales by Application (2022-2027) & (K MT)
Table 97. Southeast Asia Pharmaceutical Intermediates Sales Market Share by Application (2022-2027)
Table 98. India Pharmaceutical Intermediates Sales (K MT) by Company (2016-2021)
Table 99. India Pharmaceutical Intermediates Sales Market Share by Company (2016-2021)
Table 100. India Pharmaceutical Intermediates Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Pharmaceutical Intermediates Revenue Market Share by Company (2016-2021)
Table 102. India Pharmaceutical Intermediates Sales by Type (2016-2021) & (K MT)
Table 103. India Pharmaceutical Intermediates Sales Market Share by Type (2016-2021)
Table 104. India Pharmaceutical Intermediates Sales by Type (2022-2027) & (K MT)
Table 105. India Pharmaceutical Intermediates Sales Market Share by Type (2022-2027)
Table 106. India Pharmaceutical Intermediates Sales by Application (2016-2021) & (K MT)
Table 107. India Pharmaceutical Intermediates Sales Market Share by Application (2016-2021)
Table 108. India Pharmaceutical Intermediates Sales by Application (2022-2027) & (K MT)
Table 109. India Pharmaceutical Intermediates Sales Market Share by Application (2022-2027)
Table 110. Lonza Corporation Information
Table 111. Lonza Description and Business Overview
Table 112. Lonza Pharmaceutical Intermediates Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 113. Lonza Pharmaceutical Intermediates Product
Table 114. Lonza Recent Development
Table 115. Catalent Corporation Information
Table 116. Catalent Description and Business Overview
Table 117. Catalent Pharmaceutical Intermediates Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 118. Catalent Pharmaceutical Intermediates Product
Table 119. Catalent Recent Development
Table 120. Patheon Corporation Information
Table 121. Patheon Description and Business Overview
Table 122. Patheon Pharmaceutical Intermediates Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 123. Patheon Pharmaceutical Intermediates Product
Table 124. Patheon Recent Development
Table 125. Jubilant Corporation Information
Table 126. Jubilant Description and Business Overview
Table 127. Jubilant Pharmaceutical Intermediates Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 128. Jubilant Pharmaceutical Intermediates Product
Table 129. Jubilant Recent Development
Table 130. Granules Corporation Information
Table 131. Granules Description and Business Overview
Table 132. Granules Pharmaceutical Intermediates Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 133. Granules Pharmaceutical Intermediates Product
Table 134. Granules Recent Development
Table 135. Ganesh Corporation Information
Table 136. Ganesh Description and Business Overview
Table 137. Ganesh Pharmaceutical Intermediates Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 138. Ganesh Pharmaceutical Intermediates Product
Table 139. Ganesh Recent Development
Table 140. Chemcon Corporation Information
Table 141. Chemcon Description and Business Overview
Table 142. Chemcon Pharmaceutical Intermediates Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 143. Chemcon Pharmaceutical Intermediates Product
Table 144. Chemcon Recent Development
Table 145. BASF Corporation Information
Table 146. BASF Pharmaceutical Intermediates Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 147. BASF Description and Business Overview
Table 148. BASF Pharmaceutical Intermediates Product
Table 149. BASF Recent Development
Table 150. Porton Corporation Information
Table 151. Porton Pharmaceutical Intermediates Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 152. Porton Description and Business Overview
Table 153. Porton Pharmaceutical Intermediates Product
Table 154. Porton Recent Development
Table 155. Lianhetech Corporation Information
Table 156. Lianhetech Description and Business Overview
Table 157. Lianhetech Pharmaceutical Intermediates Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 158. Lianhetech Pharmaceutical Intermediates Product
Table 159. Lianhetech Recent Development
Table 160. ABA Chem Corporation Information
Table 161. ABA Chem Description and Business Overview
Table 162. ABA Chem Pharmaceutical Intermediates Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 163. ABA Chem Pharmaceutical Intermediates Product
Table 164. ABA Chem Recent Development
Table 165. Tianma Corporation Information
Table 166. Tianma Description and Business Overview
Table 167. Tianma Pharmaceutical Intermediates Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 168. Tianma Pharmaceutical Intermediates Product
Table 169. Tianma Recent Development
Table 170. Jiujiujiu Corporation Information
Table 171. Jiujiujiu Description and Business Overview
Table 172. Jiujiujiu Pharmaceutical Intermediates Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 173. Jiujiujiu Pharmaceutical Intermediates Product
Table 174. Jiujiujiu Recent Development
Table 175. Alpha Corporation Information
Table 176. Alpha Description and Business Overview
Table 177. Alpha Pharmaceutical Intermediates Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 178. Alpha Pharmaceutical Intermediates Product
Table 179. Alpha Recent Development
Table 180. Jiuzhou Corporation Information
Table 181. Jiuzhou Description and Business Overview
Table 182. Jiuzhou Pharmaceutical Intermediates Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 183. Jiuzhou Pharmaceutical Intermediates Product
Table 184. Jiuzhou Recent Development
Table 185. Yongtai Corporation Information
Table 186. Yongtai Description and Business Overview
Table 187. Yongtai Pharmaceutical Intermediates Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 188. Yongtai Pharmaceutical Intermediates Product
Table 189. Yongtai Recent Development
Table 190. Production Base and Market Concentration Rate of Raw Material
Table 191. Key Suppliers of Raw Materials
Table 192. Pharmaceutical Intermediates Distributors List
Table 193. Pharmaceutical Intermediates Customers List
Table 194. Pharmaceutical Intermediates Market Trends
Table 195. Pharmaceutical Intermediates Market Drivers
Table 196. Pharmaceutical Intermediates Market Challenges
Table 197. Pharmaceutical Intermediates Market Restraints
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
List of Figures
Figure 1. Pharmaceutical Intermediates Product Picture
Figure 2. Global Pharmaceutical Intermediates Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Pharmaceutical Intermediates Sales Market Share by Application in 2021 & 2027
Figure 6. Antibiotics Examples
Figure 7. Antipyretic Analgesics Examples
Figure 8. Vitamins Examples
Figure 9. Others Examples
Figure 10. Global Pharmaceutical Intermediates Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Pharmaceutical Intermediates Sales Growth Rate (2016-2027) & (US$ Million)
Figure 12. Global Pharmaceutical Intermediates Sales (K MT) Growth Rate (2016-
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs